Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Biolife Solutions Inc | 8,707,165 | 8,707,165 | 0 | $186.59M | $218.03M | 14.54% | +$31.43M |
| Revolution Medicines, Inc.(RVMD) | 4,406,875 | 4,114,283 | -292,592 | $171.03M | $186.58M | 12.44% | +$15.55M |
| GeneDx Holdings Corp.CL A(WGS) | 3,526,411 | 3,507,164 | -19,247 | $92.18M | $148.84M | 9.92% | +$56.66M |
| Standard BioTools Inc.(LAB) | 63,959,677 | 71,254,677 | +7,295,000 | $113.21M | $137.52M | 9.17% | +$24.31M |
| Sarepta Therapeutics, Inc.(SRPT) | 1,073,500 | 1,073,500 | 0 | $169.61M | $134.07M | 8.94% | -$35.54M |
| Illumina, Inc.(ILMN) | 480,000 | 750,000 | +270,000 | $50.10M | $97.81M | 6.52% | +$47.71M |
| Avidity Biosciences Inc | 2,084,841 | 2,084,841 | 0 | $85.17M | $95.76M | 6.38% | +$10.59M |
| Relay Therapeutics, Inc.(RLAY) | 8,448,574 | 9,251,108 | +802,534 | $55.08M | $65.50M | 4.37% | +$10.41M |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 170,000 | 170,000 | 0 | $41.31M | $46.76M | 3.12% | +$5.45M |
| Endeavour Silver Corp.(EXK) | 650,000 | 650,000 | 0 | $27.46M | $44.28M | 2.95% | +$16.82M |
| Intellia Therapeutics, Inc.(NTLA) | 2,000,000 | 2,000,000 | 0 | $44.76M | $41.10M | 2.74% | -$3.66M |
| Structure Therapeutics IncADS | 700,000 | 700,000 | 0 | $27.49M | $30.72M | 2.05% | +$3.23M |
| Blueprint Medicines Corp | 326,378 | 326,378 | 0 | $35.18M | $30.19M | 2.01% | -$4.99M |
| Denali Therapeutics Inc.(DNLI) | 1,300,000 | 990,000 | -310,000 | $30.19M | $28.84M | 1.92% | -$1.35M |
| Codexis, Inc.(CDXS) | 2,000,000 | 8,100,000 | +6,100,000 | $6.20M | $24.95M | 1.66% | +$18.75M |
| Veracyte, Inc.(VCYT) | 857,904 | 666,308 | -191,596 | $18.59M | $22.68M | 1.51% | +$4.09M |
| Neurogene Inc.(NGNE) | 524,616 | 524,616 | 0 | $19.09M | $22.01M | 1.47% | +$2.92M |
| Verve Therapeutics Inc | 3,059,094 | 3,995,571 | +936,477 | $14.93M | $19.34M | 1.29% | +$4.41M |
| Beam Therapeutics Inc.(BEAM) | 675,000 | 775,000 | +100,000 | $15.82M | $18.99M | 1.27% | +$3.17M |
| Tenaya Therapeutics, Inc.(TNYA) | 6,732,971 | 6,732,971 | 0 | $20.87M | $12.99M | 0.87% | -$7.88M |
| 4d Molecular Therapeutics In | 800,000 | 1,150,000 | +350,000 | $16.79M | $12.43M | 0.83% | -$4.36M |
| 2seventy Bio Inc | 2,000,000 | 2,000,000 | 0 | $7.70M | $9.44M | 0.63% | +$1.74M |
| Tango Therapeutics, Inc.(TNGX) | 1,188,349 | 1,188,349 | 0 | $10.20M | $9.15M | 0.61% | -$1.05M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 150,000 | 475,000 | +325,000 | $3.08M | $9.14M | 0.61% | +$6.06M |
| Guardant Health, Inc.(GH) | 100,000 | 350,000 | +250,000 | $2.89M | $8.03M | 0.54% | +$5.14M |
| Contineum Therapeutics, Inc.CL A(CTNM) | 296,666 | 296,666 | 0 | $5.22M | $5.68M | 0.38% | +$453.9K |
| Century Therapeutics, Inc.(IPSC) | 5,190,506 | 3,212,316 | -1,978,190 | $13.24M | $5.49M | 0.37% | -$7.74M |
| GRAIL, Inc.(GRAL) | 79,999 | 350,000 | +270,001 | $1.23M | $4.82M | 0.32% | +$3.59M |
| Absci Corporation | 973,260 | 973,260 | 0 | $3.00M | $3.72M | 0.25% | +$720.2K |
| Pacific Biosciences of California, Inc.(PACB) | 1,035,859 | 1,035,859 | 0 | $1.42M | $1.76M | 0.12% | +$341.8K |
| Prime Medicine, Inc.(PRME) | 367,175 | 367,175 | 0 | $1.89M | $1.42M | 0.09% | -$466.3K |
| Exscientia PlcADS | 213,900 | 213,900 | 0 | $1.09M | $1.04M | 0.07% | -$47.1K |
| Monte Rosa Therapeutics, Inc.(GLUE) | 261,014 | 86,014 | -175,000 | $976.2K | $455.9K | 0.03% | -$520.3K |
| Ginkgo Bioworks Holdings, Inc.CL A(DNA) | 0 | 36,493 | +36,493 | $0 | $297.4K | 0.02% | +$297.4K |
| Kronos Bio Inc | 123,839 | 123,839 | 0 | $153.6K | $123.8K | 0.01% | -$29.7K |
| Ginkgo Bioworks Holdings, Inc.CL A(DNA) | 1,459,747 | 0 | -1,459,747 | $488.0K | $0 | — | -$488.0K |
| Kyverna Therapeutics, Inc.(KYTX) | 575,000 | 0 | -575,000 | $4.31M | $0 | — | -$4.31M |
| Pliant Therapeutics, Inc.(PLRX) | 1,000,000 | 0 | -1,000,000 | $10.75M | $0 | — | -$10.75M |
| Singular Genomics Systems In | 44,129 | 0 | -44,129 | $372.9K | $0 | — | -$372.9K |